Sunshine Act Deadline Is Still Cloudy As Registration Not Yet Available
This article was originally published in The Pink Sheet Daily
Executive Summary
Physician payment data is coming due, but stakeholders continue to press CMS for clarity on the deadline for the first set of information since conflicting instructions are on the agency’s website.
You may also be interested in...
Six Months Till Sunrise: CMS Allows Extra Time For Firms To Collect Physicians Payment Data
Drug makers get three more months to comply than the proposed rule offered; firms must send the data by March 31, 2014, to CMS, which plans to make the information available on a public website by Sept. 30, 2014.
FDA’s Authority Looks Safe From Judicial Interference Following Supreme Court Abortion Pill Arguments
The agency's and the pharma industry’s worst fears – that a potential ruling in the mifepristone case might usurp the FDA’s scientific authority and throw the stability of the US drug approval process into question – seem unlikely to materialize as the majority of the Supreme Court justices signal the Alliance for Hippocratic Medicine lacks standing to sue.
Bernie Gets Mostly Pharma-Friendly Drug Pricing Results
Changes to inhaler pricing may be more ‘business as usual’ for the drug industry than the Vermont senator wants to let on. FTC, meanwhile, is keeping the patent pressure on Teva, the only inhaler manufacturer to not act following Sanders’ investigation.